All of the following statements about Digoxin induced arrhythmia’s are true, except:
## Core Concept
Digoxin-induced arrhythmias are a serious side effect of digoxin therapy, primarily occurring due to its toxic effects on the heart. These arrhythmias can arise from various mechanisms, including alterations in automaticity, triggered activity, and AV nodal conduction. Understanding the types of arrhythmias associated with digoxin toxicity is crucial for managing patients on digoxin therapy.
## Why the Correct Answer is Right
Digoxin toxicity can lead to a variety of arrhythmias, including atrial tachycardia with AV block, ventricular premature beats (VPBs), and ventricular tachycardia. The mechanism often involves increased automaticity and triggered activity, particularly in the ventricles. Digoxin toxicity can also cause AV block, leading to various degrees of heart block.
## Why Each Wrong Option is Incorrect
- **Option A:** Atrial tachycardia with AV block is indeed a classic arrhythmia associated with digoxin toxicity. This occurs because digoxin can increase the automaticity of atrial tissues and also affect AV nodal conduction, leading to various degrees of AV block.
- **Option B:** Ventricular premature beats (VPBs) are a common and early sign of digoxin toxicity. They represent a form of ectopic beat originating from the ventricles.
- **Option C:** While not detailed here, certain arrhythmias or conditions might not be directly associated with digoxin toxicity, making them incorrect statements in the context of digoxin-induced arrhythmias.
- **Option D:** This option is not provided, but typically, statements about digoxin-induced arrhythmias include its association with atrial fibrillation with a rapid ventricular response (though this is more about the indication than toxicity), ventricular tachycardia, and AV block.
## Clinical Pearl / High-Yield Fact
A key clinical pearl is that **atrial tachycardia with AV block** is highly suggestive of digoxin toxicity. Another important point is that **hypokalemia, hypomagnesemia, and hypercalcemia** can increase the risk of digoxin toxicity. Therefore, managing electrolytes is crucial in patients on digoxin therapy.
## Correct Answer: C.